NGS identification of both male and female cancer risks
Do you know a man who has participated at least once in “Movember”? Every year, thousands of men...
Detect mutations in 12 important genes associated with hereditary breast and ovarian cancers (HBOC) in a single-tube, targeted-sequencing-test that delivers ready-to-be-sequenced libraries in just 5 hours.
5
Five hours from sample to sequencing
12
Sequence 12 genes relevant for breast and ovarian cancers
45
Less than 45 minutes of hands-on time
IVD
Single end-to-end CE-IVD solution
Devyser HBOC NGS can serve as a first-line protocol in parallel with BRCA1 and BRCA2 gene variant screening, adding 12 more genes to the process. It can also be used for follow-up after negative BRCA testing. The unique single-tube format dramatically speeds up the workflow, reducing lab handling time to less than 45 minutes.
The end-to-end test kit is easy to use, making it suitable for laboratories of any size. One tube per sample avoids the need for sample splitting and minimizes any risk of sample mix-up or cross-contamination thanks to included ID markers. Embedded data interpretation software ensures accurate analysis – and fast actionable results. The kit is purpose-designed to reduce laboratory processing costs by ensuring targeted sequencing with high uniformity and by maximizing sample capacity on every next-generation sequencing flow cell.
The CE-IVD test kit is specifically designed to detect heritable germline mutations. This makes it a useful reference for clinical treatment and management decisions, as well as a valuable testing option for at-risk relatives. The included genes are ATM, PTEN, BARD1, RAD51C, RAD51D, BRIP1, CDH1, STK11, CHEK2, TP53, NBN and PALB2.
Instructions for use
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below.
Guidelines and handbooks (1)
Product information (3)
Software settings (4)
Safety data sheets (3)
Data tables (0)
Enter access code found in the lower right corner of the label on the kit box.
Download a specific Batch Release Certificate (BRC) below.
CE-IVD
Devyser HBOC NGS
Sequence variants in 12 genes known to significantly increase the risk of developing breast and ovarian cancer in germline samples. They are ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
8-A111-24
8-A111-48
Pack size: 24
Pack size: 48
RUO
Devyser HBOC NGS
Sequence variants in 12 genes known to significantly increase the risk of developing breast and ovarian cancer in germline samples. They are ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
8-A111-24-RUO
8-A111-48-RUO
Pack size: 24
Pack size: 48
Complete the form below and we will be in touch promptly.
Do you know a man who has participated at least once in “Movember”? Every year, thousands of men...
Read More
BRCA1 variants may generally be divided into three categories: benign variants, which cause no...
Read More
Check out a recent publication from Capone et al from the University of Florence!
Read More
The team at Devyser were excited to see our products put to use in a recent research project,...
Read More
Fast and effective test data analysis is crucial to achieving accurate outcomes and efficient workflows.
Dedicated software in our products makes analyzing test results quick, easy and trouble-free. For users, this means a streamlined end-to-end process with unmatched reliability and transparency.
"